Több mint 4 millió cím angol és más nyelveken! Fedezd fel új történetedet még ma!

Drug Development

Name: Drug Development
Brand: Humana Press Inc.
SKU: 9781617370878
Price: 38357 HUF
Availability: InStock

Molecular Targets for GI Diseases

Szerző: Timothy S. Gaginella, Antonio Guglietta

Nyelv:

Kötés: Puha kötésű

Kiadó: Humana Press Inc.

Elérhetőség: Beszállítói készleten

Küldés 5-8 napon belül

38 357 Ft

The application of molecular techniques to gastroenterology continues to yield important advances in...

Információk a könyvről

Szerző

Timothy S. Gaginella, Antonio Guglietta

Nyelv

Angol

Kötés

Könyv - Puha kötésű

Kiadva

2010

oldal

278

EAN

9781617370878

ISBN

1617370878

Enbook ID

02717253

Kiadó

Humana Press Inc.

Súly

430

Méretek

152 x 229 x 16

Teljes leírás

The application of molecular techniques to gastroenterology continues to yield important advances in the development of drugs to treat gastrointestinal disorders. Important new drugs have emerged through the collaborative and complementary efforts of basic scientists, clinicians, and clinical researchers in academia and the pharmaceutical industry. The challenge has been exciting, with a few surprises along the way. Consider peptic ulcer disease as an example. The discovery of H receptors and the availability of potent and 2 selective H-receptor antagonists signaled the beginning of a new era 2 in the treatment of gastric hypersecretory states and peptic ulcers. Introduction of proton pump inhibitors offered another therapeutic option. Though H-receptor antagonists and proton pump inhibitors 2 are important and useful drugs, the discovery of the link between H. pylori infection and peptic ulcer disease has led to even more effective pharmacotherapeutic regimens. Our intent in Drug Development: Molecular Targets for GI Diseases is to bring together hands-on experts to review promising areas of gastrointestinal pharmacology. The contemporary topics covered, from a mechanistic viewpoint, are relevant to gastrointestinal inflammation and motility disorders. Authoritative opinions are offered on both future research directions and potential applications for new therapies.